MicroRNA-133a, downregulated in osteosarcoma, suppresses proliferation and promotes apoptosis by targeting Bcl-xL and Mcl-1; miRNA-133b targets pro-survival molecules MCL-1 and BCL2L2 in lung cancer. Here, BCL2L2 is linked to lung carcinoma.